Novel genetic targets in endometrial cancer

Mcl-1 Ubiquitination and Destruction

(2015) Hiroyuki Inuzuka et al.   Oncotarget

CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now

(2013) Aoife O’Shaughnessy et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Therapeutic potential of serum and glucocorticoid inducible kinase inhibition

(2013) Florian Lang et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

High Frequency Strand Slippage Mutations inCTCFin MSI-Positive Endometrial Cancers

(2013) Israel Zighelboim et al.   HUMAN MUTATION

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

(2013) Jianzhao Liu et al.   Nature Chemical Biology

NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins

(2013) B. D. Burgute et al.   NUCLEIC ACIDS RESEARCH

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

(2013) S. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers

(2013) I. Kinde et al.   Science Translational Medicine

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B

(2012) S. Rao et al.   BLOOD

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer

(2012) H. Liang et al.   GENOME RESEARCH

Frequent mutations in the RPL22 gene and its clinical and functional implications

(2012) Akiva P. Novetsky et al.   GYNECOLOGIC ONCOLOGY

Genome-wide Studies of CCCTC-binding Factor (CTCF) and Cohesin Provide Insight into Chromatin Structure and Regulation: FIGURE 1.

(2012) Bum-Kyu Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

(2012) Elisabetta Kuhn et al.   JNCI-Journal of the National Cancer Institute

A Novel 4EHP-GIGYF2 Translational Repressor Complex Is Essential for Mammalian Development

(2012) M. Morita et al.   MOLECULAR AND CELLULAR BIOLOGY

Systematic identification of genomic markers of drug sensitivity in cancer cells

(2012) Mathew J. Garnett et al.   NATURE

A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response

(2012) Britt Adamson et al.   NATURE CELL BIOLOGY

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

(2012) Matthieu Le Gallo et al.   NATURE GENETICS

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

RBMX: A Regulator for Maintenance and Centromeric Protection of Sister Chromatid Cohesion

(2012) Sachihiro Matsunaga et al.   Cell Reports

Targeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole–Imidazole Polyamide

(2011) Yi Zhang et al.   BIOCHEMISTRY

PKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B

(2011) Atsushi Baba et al.   NATURE CELL BIOLOGY

Emerging therapeutic targets in endometrial cancer

(2011) Konstantin J. Dedes et al.   Nature Reviews Clinical Oncology

Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression

(2010) Marija Mihailovich et al.   BIOESSAYS

NKAP Is a Transcriptional Repressor of Notch Signaling and Is Required for T Cell Development

(2009) Anthony G. Pajerowski et al.   IMMUNITY

Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA

(2009) Bettina Heinrich et al.   JOURNAL OF BIOLOGICAL CHEMISTRY